Biocon drug gets nod for use in moderate to severe COVID-19 patients

Biotechnology major Biocon on Saturday announced that its 'breakthrough drug', Itolizumab has received Drugs Controller General of India's (DCGI) approval for its use in moderate to......

Drug controller okays Psoriasis injection for COVID-19 patients

India's drug regulator has approved Itolizumab, used to cure skin ailment psoriasis, for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress, officials......

Health min recommends anti-malarial drug for COVID-19

The Union Health Ministry has recommended the use of anti-malarial drug hydroxychloroquine in combination with azithromycin on those severely suffering from COVID-19 who require ICU management.......

Another COVID-19 patient dies in Mumbai; Maha toll reaches 2

A 63-year-old coronavirus patient died in Mumbai on Sunday, taking the death toll in Maharashtra to two, a health official said. IMAGE: Men wear masks to mitigate the coronavirus......

Steel firms may cut HR rates

The steel industry, after a periodic increase in prices over the last year, is bracing for a successive price cuts with rates of hot rolled products likely to soften further by Rs 500-700 next......

Elite athletes at risk of coronavirus spread to lungs

Due to strenuous exercise, elite athletes are more likely to inhale virus particles and direct them to the lower areas of the lung Athletes who are asymptomatic could make their condition worse by......